sveSVENSKA   |   polPOLSKI   |   engENGLISH

+48 12 42 25 850 (Cracow) / +46 8 556 063 50 (Stockholm)     LinkedIN     Twitter

The SME-Instrument: 3,6 million Euro to SymCel

Date:
Tuesday, 05 December 2017

In good cooperation with SymCel, GAEU Consulting first wrote a Phase 1 application within the Horizon 2020 SME-Instrument that got approved and then wrote the Phase 2 application that granted the company 3,6 million for clinical validation of customized antimicrobial susceptibility testing.

pressrelease 820x340

– Thank you to all involved in SymCel and GAEUs production teams! 

http://symcel.se/2017/11/21/symcel-secures-e3-6-million-for-antibiotic-susceptibility-testing/

Share with others